Anchor Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Anchor Investment Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.34K	Hold	58	–	–	﹤0.01%	957
2026 Q1	$6.03K	Hold	58	–	–	﹤0.01%	879
2025 Q4	$5.98K	Hold	58	–	–	﹤0.01%	879
2025 Q3	$5.24K	Hold	58	–	–	﹤0.01%	898
2025 Q2	$5.1K	Hold	58	–	–	﹤0.01%	887
2025 Q1	$5.29K	Hold	58	–	–	﹤0.01%	873
2024 Q4	$5K	Hold	58	–	–	﹤0.01%	880
2024 Q3	$5.51K	Hold	58	–	–	﹤0.01%	866
2024 Q2	$5.31K	Hold	58	–	–	﹤0.01%	837
2024 Q1	$5.26K	Hold	58	–	–	﹤0.01%	859
2023 Q4	$4.72K	Hold	58	–	–	﹤0.01%	821
2023 Q3	$4.63K	Hold	58	–	–	﹤0.01%	837
2023 Q2	$4.57K	Hold	58	–	–	﹤0.01%	838
2023 Q1	$4.5K	Hold	58	–	–	﹤0.01%	845
2022 Q4	$4.51K	Hold	58	–	–	﹤0.01%	809
2022 Q3	$3.9K	Hold	58	–	–	﹤0.01%	832
2022 Q2	$4.46K	Hold	58	–	–	﹤0.01%	825
2022 Q1	$4.63K	Hold	58	–	–	﹤0.01%	853
2021 Q4	$4.46K	Hold	58	–	–	﹤0.01%	881
2021 Q3	$4.22K	Hold	58	–	–	﹤0.01%	800
2021 Q2	$4.24K	Hold	58	–	–	﹤0.01%	822
2021 Q1	$4K	Hold	58	–	–	﹤0.01%	806
2020 Q4	$3.85K	Hold	58	–	–	﹤0.01%	783
2020 Q3	$3.61K	Hold	58	–	–	﹤0.01%	760
2020 Q2	$3.61K	Hold	58	–	–	﹤0.01%	740
2020 Q1	$3.15K	Hold	58	–	–	﹤0.01%	729
2019 Q4	$3.72K	Hold	58	–	–	﹤0.01%	730
2019 Q3	$3.31K	Hold	58	–	–	﹤0.01%	727
2019 Q2	$3.4K	Hold	58	–	–	﹤0.01%	717
2019 Q1	$3.52K	Hold	58	–	–	﹤0.01%	714
2018 Q4	$3.18K	Hold	58	–	–	﹤0.01%	732
2018 Q3	$3.73K	Hold	58	–	–	﹤0.01%	748
2018 Q2	$3.42K	Hold	58	–	–	﹤0.01%	767
2018 Q1	$3.3K	Hold	58	–	–	﹤0.01%	741
2017 Q4	$3.44K	Buy	+58	New	+$3.33K	﹤0.01%	742

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Anchor Investment Management's PPH Position: Q2 2026 in Review

Anchor Investment Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 58 shares worth $6.34K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Anchor Investment Management first reported a position in PPH in Q4 2017 and has held it in 35 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Anchor Investment Management held 58 shares of VanEck Pharmaceutical ETF worth $6.34K as of Q2 2026.
Anchor Investment Management left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
VanEck Pharmaceutical ETF made up ﹤0.01% of Anchor Investment Management's portfolio in Q2 2026, its #957 holding.
Anchor Investment Management first reported a position in VanEck Pharmaceutical ETF in Q4 2017 and has held it in 35 quarters since.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Anchor Investment Management's 13F filing for Q2 2026, filed 15 Sep 2026.